EC

EcoR1 Capital Portfolio holdings

AUM $2.08B
1-Year Est. Return 69.18%
This Quarter Est. Return
1 Year Est. Return
+69.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.69B
AUM Growth
+$3.51M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
50
New
Increased
Reduced
Closed

Top Buys

1
+$107M
2
+$71.7M
3
+$24.7M
4
VRNA
Verona Pharma
VRNA
+$18.9M
5
ALKS icon
Alkermes
ALKS
+$14.3M

Top Sells

1
+$143M
2
+$82.5M
3
+$18.3M
4
BEAM icon
Beam Therapeutics
BEAM
+$10.3M
5
DNA icon
Ginkgo Bioworks
DNA
+$8.34M

Sector Composition

1 Healthcare 99.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
26
Pacira BioSciences
PCRX
$1.02B
$10.9M 0.65%
+457,471
REPL icon
27
Replimune Group
REPL
$705M
$7.9M 0.47%
850,341
MTSR
28
DELISTED
Metsera Inc
MTSR
$7.72M 0.46%
271,529
+221,529
ADAP
29
DELISTED
Adaptimmune Therapeutics
ADAP
$6.57M 0.39%
27,404,070
DAWN icon
30
Day One Biopharmaceuticals
DAWN
$904M
$5.6M 0.33%
862,068
HLVX
31
DELISTED
HilleVax
HLVX
$4.82M 0.29%
+2,420,243
ATRA icon
32
Atara Biotherapeutics
ATRA
$96.6M
$4.42M 0.26%
573,183
WHWK
33
Whitehawk Therapeutics
WHWK
$101M
$2.04M 0.12%
1,091,417
-990,583
MGNX icon
34
MacroGenics
MGNX
$94.9M
$1.94M 0.11%
+1,602,717
NUVB.WS icon
35
Nuvation Bio Inc Warrants
NUVB.WS
$32.5M
$1.88M 0.11%
963,333
SRZNW icon
36
Surrozen Inc Warrant
SRZNW
$44.6K
$596K 0.04%
66,665
ALGS icon
37
Aligos Therapeutics
ALGS
$41M
– –
-88,569
BCYC
38
Bicycle Therapeutics
BCYC
$450M
– –
-910,000
BEAM icon
39
Beam Therapeutics
BEAM
$2.2B
– –
-526,685
DNA icon
40
Ginkgo Bioworks
DNA
$487M
– –
-1,462,328
KROS icon
41
Keros Therapeutics
KROS
$526M
– –
-187,500
PRME icon
42
Prime Medicine
PRME
$608M
– –
-700,000
PRTA icon
43
Prothena Corp
PRTA
$535M
– –
-11,584,280
RLAY icon
44
Relay Therapeutics
RLAY
$1.09B
– –
-641,426
SLDB icon
45
Solid Biosciences
SLDB
$330M
– –
-744,450
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.97B
– –
-1,292,386
TCRX icon
47
TScan Therapeutics
TCRX
$62.4M
– –
-662,833
VERV
48
DELISTED
Verve Therapeutics
VERV
– –
-1,250,000
UPB
49
Upstream Bio Inc
UPB
$1.33B
– –
-60,000
KLRS
50
Kalaris Therapeutics
KLRS
$102M
– –
-201,718
1
2